Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeutic.
Saved in:
| Title: | Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeutic. |
|---|---|
| Authors: | Kang MS; Translational Neuroimaging Laboratory, McGill University Research Centre for Studying in Aging, Montreal, QC, Canada.; Douglas Mental Health University Institute, Montreal, Canada.; McConnell Brain Imaging Centre, McGill University, Montreal, QC, Canada., Shin M; Translational Neuroimaging Laboratory, McGill University Research Centre for Studying in Aging, Montreal, QC, Canada.; Douglas Mental Health University Institute, Montreal, Canada., Ottoy J; Translational Neuroimaging Laboratory, McGill University Research Centre for Studying in Aging, Montreal, QC, Canada., Aliaga AA; Translational Neuroimaging Laboratory, McGill University Research Centre for Studying in Aging, Montreal, QC, Canada.; Douglas Mental Health University Institute, Montreal, Canada.; McConnell Brain Imaging Centre, McGill University, Montreal, QC, Canada., Mathotaarachchi S; Translational Neuroimaging Laboratory, McGill University Research Centre for Studying in Aging, Montreal, QC, Canada.; Douglas Mental Health University Institute, Montreal, Canada., Quispialaya K; Translational Neuroimaging Laboratory, McGill University Research Centre for Studying in Aging, Montreal, QC, Canada., Pascoal TA; Translational Neuroimaging Laboratory, McGill University Research Centre for Studying in Aging, Montreal, QC, Canada.; Douglas Mental Health University Institute, Montreal, Canada., Collins DL; McConnell Brain Imaging Centre, McGill University, Montreal, QC, Canada., Chakravarty MM; Douglas Mental Health University Institute, Montreal, Canada., Mathieu A; Douglas Mental Health University Institute, Montreal, Canada., Sandelius Å; Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden., Blennow K; Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden., Zetterberg H; Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; UK Dementia Research Institute at UCL, London, UK.; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK., Massarweh G; McConnell Brain Imaging Centre, McGill University, Montreal, QC, Canada., Soucy JP; McConnell Brain Imaging Centre, McGill University, Montreal, QC, Canada., Cuello AC; Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada., Gauthier S; Translational Neuroimaging Laboratory, McGill University Research Centre for Studying in Aging, Montreal, QC, Canada.; Douglas Mental Health University Institute, Montreal, Canada.; McConnell Brain Imaging Centre, McGill University, Montreal, QC, Canada., Waterston M; Centre for Imaging Technology Commercialization, London, ON, Canada., Yoganathan N; KalGene Pharmaceuticals Inc., Montreal, Canada., Lessard E; Human Health Therapeutics, National Research Council of Canada, Ottawa, ON, Canada., Haqqani A; Human Health Therapeutics, National Research Council of Canada, Ottawa, ON, Canada., Rennie K; Human Health Therapeutics, National Research Council of Canada, Ottawa, ON, Canada., Stanimirovic D; Human Health Therapeutics, National Research Council of Canada, Ottawa, ON, Canada., Chakravarthy B; Human Health Therapeutics, National Research Council of Canada, Ottawa, ON, Canada., Rosa-Neto P; Translational Neuroimaging Laboratory, McGill University Research Centre for Studying in Aging, Montreal, QC, Canada.; Douglas Mental Health University Institute, Montreal, Canada.; McConnell Brain Imaging Centre, McGill University, Montreal, QC, Canada. |
| Source: | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism [J Cereb Blood Flow Metab] 2022 May; Vol. 42 (5), pp. 788-801. Date of Electronic Publication: 2021 Aug 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 8112566 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-7016 (Electronic) Linking ISSN: 0271678X NLM ISO Abbreviation: J Cereb Blood Flow Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1559-7016 |
|---|---|
| DOI: | 10.1177/0271678X211035625 |
